Tectonic Therapeutic Capital Expenditures (CapEx) Growth & History (TECX)
Tectonic Therapeutic's capital expenditures (capex) was $208,000 for fiscal 2025.
View full Tectonic Therapeutic company overviewTectonic Therapeutic annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $208,000 | $52,000 | +33.33% |
| 2024 | 2024-12-31 | $156,000 | −$123,000 | −44.09% |
| 2023 | 2023-12-31 | $279,000 | $12,000 | +4.49% |
| 2022 | 2022-12-31 | $267,000 | −$2.2M | −89.15% |
| 2021 | 2021-12-31 | $2.5M | $1.3M | +109.09% |
| 2020 | 2020-12-31 | $1.2M | −$408,000 | −25.74% |
| 2019 | 2019-12-31 | $1.6M | −$247,000 | −13.48% |
| 2018 | 2018-12-31 | $1.8M | $1.4M | +378.33% |
| 2017 | 2017-12-31 | $383,000 | — | — |
Tectonic Therapeutic quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $79,000 | $79,000 | — |
| Q1 2026 | 2026-03-31 | $19,000 | −$8,000 | −29.63% |
| Q4 2025 | 2025-12-31 | $0 | −$3,000 | — |
| Q3 2025 | 2025-09-30 | $181,000 | $28,000 | +18.30% |
| Q2 2025 | 2025-06-30 | $0 | −$4,000 | — |
| Q1 2025 | 2025-03-31 | $27,000 | $23,000 | +575.00% |
| Q4 2024 | 2024-12-31 | $3,000 | −$47,000 | −94.00% |
| Q3 2024 | 2024-09-30 | $153,000 | $146,000 | +2085.71% |
| Q2 2024 | 2024-06-30 | $4,000 | −$210,000 | −98.13% |
| Q1 2024 | 2024-03-31 | $4,000 | −$4,000 | −50.00% |
| Q4 2023 | 2023-12-31 | $50,000 | $50,000 | — |
| Q3 2023 | 2023-09-30 | $7,000 | −$79,000 | −91.86% |
| Q2 2023 | 2023-06-30 | $214,000 | $65,000 | +43.62% |
| Q1 2023 | 2023-03-31 | $8,000 | −$24,000 | −75.00% |
| Q4 2022 | 2022-12-31 | $0 | −$850,000 | — |
| Q3 2022 | 2022-09-30 | $86,000 | −$181,000 | −67.79% |
| Q2 2022 | 2022-06-30 | $149,000 | −$1.1M | −87.88% |
| Q1 2022 | 2022-03-31 | $32,000 | −$83,000 | −72.17% |
| Q4 2021 | 2021-12-31 | $850,000 | $769,000 | +949.38% |
| Q3 2021 | 2021-09-30 | $267,000 | $236,000 | +761.29% |
| Q2 2021 | 2021-06-30 | $1.2M | $741,000 | +151.84% |
| Q1 2021 | 2021-03-31 | $115,000 | −$462,000 | −80.07% |
| Q4 2020 | 2020-12-31 | $81,000 | −$685,000 | −89.43% |
| Q3 2020 | 2020-09-30 | $31,000 | −$47,000 | −60.26% |
| Q2 2020 | 2020-06-30 | $488,000 | $87,000 | +21.70% |
| Q1 2020 | 2020-03-31 | $577,000 | $237,000 | +69.71% |
| Q4 2019 | 2019-12-31 | $766,000 | $273,000 | +55.38% |
| Q3 2019 | 2019-09-30 | $78,000 | −$837,000 | −91.48% |
| Q2 2019 | 2019-06-30 | $401,000 | $240,000 | +149.07% |
| Q1 2019 | 2019-03-31 | $340,000 | $77,000 | +29.28% |
| Q4 2018 | 2018-12-31 | $493,000 | — | — |
| Q3 2018 | 2018-09-30 | $915,000 | $675,000 | +281.25% |
| Q2 2018 | 2018-06-30 | $161,000 | — | — |
| Q1 2018 | 2018-03-31 | $263,000 | — | — |
| Q3 2017 | 2017-09-30 | $240,000 | — | — |
Tectonic Therapeutic capital expenditures (capex) trends
Over the last five fiscal years, Tectonic Therapeutic's capital expenditures (capex) decreased from $1.2M to $208,000, a change of −$969,000. The latest reported quarter, Q2 2026, shows $79,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tectonic Therapeutic source filings ↗